arrow
R

Radha Krishan Shandil

foundation for neglected disease research
H指数:24
被引数:2,902

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Oral Antiviral Combination Against Severe COVID‐19 Enabled by the Synergistic Mechanisms of Action of Auranofin and Remdesivir

奥瑞夫林和瑞德西韦协同作用机制介导的口服抗病毒联合疗法治疗重症COVID‐19

2026-10-220
OA
FNDR-11124, a broad-spectrum small molecule inhibitor of viral RNA polymerase, restricts replication of SARS-CoV-2 and Influenza virus in vitro and in vivo

FNDR-11124,一种广谱病毒RNA聚合酶小分子抑制剂,在体外和体内均能抑制SARS-CoV-2和流感病毒的复制。

2026-03-020
PRE
Notch signaling stabilizes lengths of motile cilia in multiciliated cells in the lung

Notch信号通路稳定肺多纤毛细胞中运动性纤毛的长度

2026-01-221
PRE
Multicentre preclinical profiling of apramycin for the treatment of nontuberculous mycobacteria

多中心非临床评估阿普霉素对非结核分枝杆菌的治疗作用

2025-12-310
OAAI
Homoharringtonine Inhibits CVS-11 and Clinical Isolates of Rabies Virus In Vitro: Identified via High-Throughput Screening of an FDA-Approved Drug Library

Homoharringtonine 在体外抑制 CVS-11 和临床分离的狂犬病病毒:通过高通量筛选 FDA 批准药物库鉴定

2025-08-220
PRE
Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria
2024-03-054
OAAI
Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo
2023-08-015
OAAI
Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis

二甲双胍联合抗结核药物治疗成人肺结核早期痰菌转阴的随机试验

2021-11-2636
OAAI
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity

支架变形以鉴定具有抗分枝杆菌活性的新型DprE1抑制剂

2019-09-2330
OAAI
Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
2017-02-0395
PREAI